Maria Andreea Catana, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory-Gated Imaging Techniques | 1 | 2018 | 71 | 0.610 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 292 | 0.570 |
Why?
|
| Liver Transplantation | 4 | 2020 | 2119 | 0.480 |
Why?
|
| Abdomen | 2 | 2018 | 1118 | 0.440 |
Why?
|
| Hepatitis, Autoimmune | 2 | 2021 | 141 | 0.350 |
Why?
|
| Liver Neoplasms | 4 | 2020 | 4253 | 0.290 |
Why?
|
| Liver Cirrhosis | 4 | 2020 | 1863 | 0.270 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 423 | 0.230 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6234 | 0.210 |
Why?
|
| Liver Diseases | 3 | 2020 | 1253 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2020 | 2214 | 0.150 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2020 | 161 | 0.150 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 380 | 0.140 |
Why?
|
| Hepatocytes | 3 | 2008 | 1211 | 0.130 |
Why?
|
| Motion | 1 | 2018 | 798 | 0.120 |
Why?
|
| Superoxide Dismutase | 2 | 2007 | 597 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.110 |
Why?
|
| Minority Groups | 1 | 2020 | 1223 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.100 |
Why?
|
| Fetal Stem Cells | 1 | 2008 | 10 | 0.080 |
Why?
|
| Lentivirus | 2 | 2008 | 501 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2015 | 1367 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7785 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 405 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2015 | 1591 | 0.070 |
Why?
|
| Thymoma | 1 | 2006 | 186 | 0.060 |
Why?
|
| Thoracic Neoplasms | 1 | 2006 | 268 | 0.060 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 167 | 0.060 |
Why?
|
| Gene Transfer Techniques | 2 | 2007 | 1224 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2015 | 3209 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Male | 12 | 2021 | 350118 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2004 | 477 | 0.050 |
Why?
|
| Middle Aged | 10 | 2021 | 213383 | 0.050 |
Why?
|
| Americas | 1 | 2021 | 111 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 501 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1294 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2020 | 528 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1620 | 0.040 |
Why?
|
| Adult | 7 | 2021 | 214055 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 592 | 0.040 |
Why?
|
| Humans | 17 | 2021 | 744343 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1701 | 0.040 |
Why?
|
| Female | 10 | 2021 | 380194 | 0.040 |
Why?
|
| Hospitalization | 3 | 2021 | 10262 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15540 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3086 | 0.040 |
Why?
|
| End Stage Liver Disease | 1 | 2020 | 314 | 0.030 |
Why?
|
| Creatinine | 1 | 2020 | 1919 | 0.030 |
Why?
|
| Registries | 2 | 2020 | 8089 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.030 |
Why?
|
| Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2020 | 40561 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 163280 | 0.030 |
Why?
|
| Albumins | 2 | 2008 | 569 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2007 | 11483 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2008 | 2716 | 0.030 |
Why?
|
| Culture Media | 2 | 2004 | 908 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57776 | 0.030 |
Why?
|
| Stem Cells | 1 | 2004 | 3567 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2020 | 9146 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 72290 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2008 | 46 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 5892 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 164 | 0.020 |
Why?
|
| Graft Survival | 2 | 2008 | 3737 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 295 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 898 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 16689 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
| Carcinogens | 1 | 2008 | 466 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 7149 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.020 |
Why?
|
| Transgenes | 1 | 2007 | 1009 | 0.010 |
Why?
|
| Cations | 1 | 2004 | 232 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1547 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 270 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 85781 | 0.010 |
Why?
|
| Superoxides | 1 | 2004 | 387 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5391 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Mice | 5 | 2008 | 81183 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 589 | 0.010 |
Why?
|
| Urea | 1 | 2004 | 450 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2362 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 759 | 0.010 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 2478 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 2307 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 3420 | 0.010 |
Why?
|
| Ethanol | 1 | 2004 | 1342 | 0.010 |
Why?
|
| Animals | 5 | 2008 | 168757 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 5882 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2216 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2004 | 1951 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1678 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3617 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 5179 | 0.010 |
Why?
|
| Cholesterol | 1 | 2004 | 2917 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2504 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 15997 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 3305 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19229 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11366 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 21827 | 0.010 |
Why?
|
| Insulin | 1 | 2004 | 6580 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18029 | 0.010 |
Why?
|
| Liver | 1 | 2004 | 7474 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 9583 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40075 | 0.000 |
Why?
|